{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T20:39:51Z","timestamp":1780605591283,"version":"3.54.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,20]]},"DOI":"10.7759\/cureus.86417","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T10:47:16Z","timestamp":1750416436000},"source":"Crossref","is-referenced-by-count":1,"title":["Immune Thrombocytopenia in a 94-Year-Old Woman: Challenges in Diagnosis and Management of an Uncommon Presentation in the Elderly"],"prefix":"10.7759","author":[{"given":"Katherine","family":"Thornburgh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor F","family":"Faust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L","family":"Horton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Immune thrombocytopenia","author":"Pietras NM","year":"2024","unstructured":"Pietras NM, Gupta N, Justiz Vaillant AA, Pearson-Shaver AL. Immune thrombocytopenia. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm6020016","article-title":"Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP)","volume":"6","author":"Zufferey A","year":"2017","unstructured":"Zufferey A, Kapur R, Semple JW. Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP). J Clin Med. 2017, 6:10.3390\/jcm6020016","journal-title":"J Clin Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23262","article-title":"Prevalence of primary immune thrombocytopenia in Oklahoma","volume":"87","author":"Terrell DR","year":"2012","unstructured":"Terrell DR, Beebe LA, Neas BR, Vesely SK, Segal JB, George JN. Prevalence of primary immune thrombocytopenia in Oklahoma. Am J Hematol. 2012, 87:848-52. 10.1002\/ajh.23262","journal-title":"Am J Hematol"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V94.3.909.415k02_909_913","article-title":"The incidence of idiopathic thrombocytopenic purpura in adults increases with age","volume":"94","author":"Frederiksen H","year":"1999","unstructured":"Frederiksen H, Schmidt K. The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood. 1999, 94:909-13.","journal-title":"Blood"},{"key":"ref5","article-title":"Adverse reactions of prophylactic intravenous immunoglobulin; a 13-year experience with 3004 infusions in Iranian patients with primary immunodeficiency diseases","volume":"19","author":"Dashti-Khavidaki S","year":"2009","unstructured":"Dashti-Khavidaki S, Aghamohammadi A, Farshadi F, et al.. Adverse reactions of prophylactic intravenous immunoglobulin; a 13-year experience with 3004 infusions in Iranian patients with primary immunodeficiency diseases. J Investig Allergol Clin Immunol. 2009, 19:139-45.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-01-129155","article-title":"The ITP syndrome: pathogenic and clinical diversity","volume":"113","author":"Cines DB","year":"2009","unstructured":"Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity. Blood. 2009, 113:6511-21. 10.1182\/blood-2009-01-129155","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103820","article-title":"Recent advances in the mechanisms and treatment of immune thrombocytopenia","volume":"76","author":"Provan D","year":"2022","unstructured":"Provan D, Semple JW. Recent advances in the mechanisms and treatment of immune thrombocytopenia. EBioMedicine. 2022, 76:10.1016\/j.ebiom.2022.103820","journal-title":"EBioMedicine"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01299","article-title":"Adverse effects of immunoglobulin therapy","volume":"9","author":"Guo Y","year":"2018","unstructured":"Guo Y, Tian X, Wang X, Xiao Z. Adverse effects of immunoglobulin therapy. Front Immunol. 2018, 9:10.3389\/fimmu.2018.01299","journal-title":"Front Immunol"},{"key":"ref9","unstructured":"Platelet disorders - immune thrombocytopenia (ITP). (2022). Accessed. September 15, 2024: https:\/\/www.nhlbi.nih.gov\/health\/immune-thrombocytopenia."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra010501","article-title":"Immune thrombocytopenic purpura","volume":"346","author":"Cines DB","year":"2002","unstructured":"Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med. 2002, 346:995-1008. 10.1056\/NEJMra010501","journal-title":"N Engl J Med"},{"key":"ref11","article-title":"Immune thrombocytopenia: pathogenesis and treatment approaches","volume":"5","author":"Raj AB","year":"2017","unstructured":"Raj AB. Immune thrombocytopenia: pathogenesis and treatment approaches. J Hematol Transfus. 2017, 5:1-9.","journal-title":"J Hematol Transfus"},{"key":"ref12","article-title":"Clinical practice updates in the management of immune thrombocytopenia","volume":"42","author":"Khan AM","year":"2017","unstructured":"Khan AM, Mydra H, Nevarez A. Clinical practice updates in the management of immune thrombocytopenia. P T. 2017, 42:756-63.","journal-title":"P T"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-162503","article-title":"Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group","volume":"113","author":"Rodeghiero F","year":"2009","unstructured":"Rodeghiero F, Stasi R, Gernsheimer T, et al.. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009, 113:2386-93. 10.1182\/blood-2008-07-162503","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-08-302984","article-title":"The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia","volume":"117","author":"Neunert C","year":"2011","unstructured":"Neunert C, Lim W, Crowther M, Cohen A, Solberg L Jr, Crowther MA. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood. 2011, 117:4190-207. 10.1182\/blood-2010-08-302984","journal-title":"Blood"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMct1014202","article-title":"Thrombopoietin-receptor agonists for primary immune thrombocytopenia","volume":"365","author":"Imbach P","year":"2011","unstructured":"Imbach P, Crowther M. Thrombopoietin-receptor agonists for primary immune thrombocytopenia. N Engl J Med. 2011, 365:734-41. 10.1056\/NEJMct1014202","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/315241-immune-thrombocytopenia-in-a-94-year-old-woman-challenges-in-diagnosis-and-management-of-an-uncommon-presentation-in-the-elderly","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T10:47:17Z","timestamp":1750416437000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/315241-immune-thrombocytopenia-in-a-94-year-old-woman-challenges-in-diagnosis-and-management-of-an-uncommon-presentation-in-the-elderly"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.86417","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6,20]]}}}